New wireless sensor could let hydrocephalus patients monitor brain pressure at home

NCT ID NCT06402786

Ongoing Disease control Sponsor: University of Auckland, New Zealand Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new wireless sensor placed in the brain during shunt surgery for hydrocephalus. The sensor aims to let patients and caregivers monitor brain pressure from home, reducing the need for hospital scans and easing fear of shunt blockages. It is a first-in-human safety trial with 21 participants, focusing on whether the device is safe over 3 to 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Kitea ICP Sensor (a wireless device implanted in the brain during shunt surgery)
What this could lead to: If successful, this could give patients and caregivers a way to monitor brain pressure at home, potentially catching dangerous blockages early and reducing emergency hospital visits.
What could go wrong: This is a very early, small safety study with only 21 participants, so it may not prove the device works reliably. There are also risks of infection or device malfunction from the implanted sensor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYDROCEPHALUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hydrocephalus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYDROCEPHALUS

Contacts and locations

Locations

Auckland City Hospital

Auckland, New Zealand

More trials for these conditions

Other studies related to the condition(s) this trial covers.